The Transferrin Receptor-Directed CAR for the Therapy of Hematologic Malignancies

As many patients ultimately relapse after chimeric antigen receptor (CAR) T-cell therapy, identification of alternative targets is currently being evaluated. Substantial research efforts are underway to develop new targets. The transferrin receptor (TfR) is prevalently expressed on rapidly prolifera...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Immunol
Main Authors: Guo, Zilong, Zhang, Yirui, Fu, Mingpeng, Zhao, Liang, Wang, Zhen, Xu, Zhuoshuo, Zhu, Huifen, Lan, Xiaoli, Shen, Guanxin, He, Yong, Lei, Ping
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2021
Assuntos:
Immunology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8039461/
https://ncbi.nlm.nih.gov/pubmed/33854512
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.652924
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados